Treatment Variation in Older Adults With Differentiated Thyroid Cancer

被引:4
|
作者
Sutton, Whitney [1 ]
Canner, Joseph K. [1 ]
Segev, Dorry L. [1 ]
Zeiger, Martha A. [2 ]
Mathur, Aarti [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Surg, 600 North Wolfe St,Blalock 606, Baltimore, MD 21287 USA
[2] NCI, Dept Surg Oncol, NIH, Bethesda, MD 20892 USA
关键词
Thyroid cancer; Aging; Thyroidectomy; Disease-specific mortality; ASSOCIATION MANAGEMENT GUIDELINES; UNITED-STATES; YOUNG AGE; PAPILLARY; SURVIVAL; PREDICTORS; PROGNOSIS; MORTALITY; NODULES; PATIENT;
D O I
10.1016/j.jss.2020.04.013
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: The growth of the aging population coupled with the increasing incidence of thyroid cancer warrants a better understanding of thyroid cancer in older adults. We aimed to investigate the variation of treatment patterns and determine if the extent of surgery is associated with disease-specific mortality in older adults with differentiated thyroid cancer (DTC). Methods: We performed a population-based study using the Surveillance, Epidemiology, and End Results 18 program to examine patients diagnosed with DTC between 2004 and 2015. Patients were stratified by age: younger adults (aged 18-54 y), middle adults (aged 5564 y), older adults (aged 65-79 y), and super elderly (aged >= 80 y). Disease-specific mortality was estimated using Kaplan-Meier curves and compared using the log-rank test. Multi variable Cox regression was used to assess associations between clinicopathologic characteristics and treatment patterns on disease-specific mortality. Results: Of 117,098 patients with DTC, 72,368 were younger adults, 23,726 middle adults, 18,119 older adults, and 2885 were super elderly. In patients with DTC, compared with younger adults, fewer middle, older, and super elderly adults underwent any surgery (99.0%, 98.4%, 97.4%, and 89.1%, respectively; P < 0.001) or received radioactive iodine (RAI; 48.7%, 42.5%, 39.7%, and 30.7%, respectively; P < 0.001). Furthermore, middle, older, and super elderly adults had higher risk of mortality from DTC (hazard ratio [HR]: 4.0, 95% confidence interval [CI]: 3.2-4.8, P < 0.001; HR: 7.6, 95% CI: 6.3-9.1, P < 0.001; and HR: 17.2, 95% CI: 13.8-21.3, P < 0.001, respectively). On multivariable Cox regression while adjusting for clinicopathologic confounders, management was a significant prognostic factor (no surgery HR: 3.8, 95% CI: 3.1-4.6, P < 0.001; and RAI HR: 0.7, 95% CI: 0.6-0.8, P < 0.001). Conclusions: In patients with DTC, fewer older adults (>= 65 y) underwent surgery or treatment with RAI, and this was associated with a worse disease-specific survival. Surgical decision-making in the older population is complex, and future prospective studies are needed to assess this age-related treatment variation. (c) 2020 Elsevier Inc. All rights reserved.
引用
收藏
页码:154 / 164
页数:11
相关论文
共 50 条
  • [22] Initial Treatment of Progressive Differentiated Thyroid Cancer
    Tuttle, R. Michael
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (05) : 3 - 6
  • [23] Dosimetric Assesment In The Treatment Of Differentiated Thyroid Cancer
    Moreno, C. Sandoval
    Nogueira, M. Tagliatori
    Marcos, V. Lopez
    Marcos, M. de la Rubia
    Arroba, B. Manzarbeitia
    Moreno, M. Alvarez
    Sanchez, M. Santamaria
    Breton, M. Balsa
    Hernandez, M. Herraez
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S586 - S586
  • [24] Changing Paradigm in Treatment of Differentiated Thyroid Cancer
    Krishna B.A.
    Mohammed Saleel K.
    Indian Journal of Surgical Oncology, 2022, 13 : 46 - 50
  • [25] SPECT/CT in the Treatment of Differentiated Thyroid Cancer
    Lee S.-W.
    Nuclear Medicine and Molecular Imaging, 2017, 51 (4) : 297 - 303
  • [26] Targeted Treatment of Differentiated and Medullary Thyroid Cancer
    Bales, Shannon R.
    Chopra, Inder J.
    JOURNAL OF THYROID RESEARCH, 2011, 2011
  • [27] The use of dosimetry in the treatment of differentiated thyroid cancer
    Lassmann, M.
    Haenscheid, H.
    Verburg, F. A.
    Luster, M.
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 55 (02): : 107 - 115
  • [28] New era for treatment in differentiated thyroid cancer
    Haraldsdottir, Sigurdis
    Shah, Manisha H.
    LANCET, 2014, 384 (9940): : 286 - 288
  • [29] Older Adults and Cancer Treatment
    Given, Barbara
    Given, Charles W.
    CANCER, 2008, 113 (12) : 3505 - 3511
  • [30] CHARACTERISTICS AND SURVIVAL OF ADULTS WITH DIFFERENTIATED THYROID CANCER IN A PERUVIAN HOSPITAL
    Morales-Concha, Luz
    Huamani-Linares, Ivan
    Saihua-Palomino, Katy
    Florez, Edward Luque
    Echevarria, Alexi Chavez
    Palomino, Ramiro Jorge Tupayachi
    Nunez, Carlos Antonio Zea
    Mejia, Christian R.
    Atamari-Anahui, Noe
    REVISTA PERUANA DE MEDICINA EXPERIMENTAL Y SALUD PUBLICA, 2024, 41 (03): : 287 - 293